This is a double blind placebo controlled study to determine whether starting allopurinol during a treated acute gout attack will have any effect on the duration of the attack.
Traditional teaching holds that starting allopurinol during an acute gout attack will prolong the attack. Recent expert opinion from the American College of Rheumatology Guidelines is that allopurinol may be started during an acute, treated gout attack. This study is designed to test the hypothesis that allopurinol does not prolong an acute, treated gout attack. Patients will either take allopurinol capsules or and identical capsule containing no allopurinol (placebo) over 28 days, starting within 72 hours of a gout attack that is being treated with other standard measures. During the study, neither the patient nor the examiner will know what pills are being taken. The time to resolution of the attack is the primary outcome measure. Pain level, serum uric acid level, and complications of therapy will also be monitored. A minimum of 32 patients completing the study are needed for a meaningful conclusion.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
35
Wilford Hall Ambulatory Surgical Center
Lackland Air Force Base, Texas, United States
Resolution of the Acute Gout Attack
The primary outcome unit of measurement is time (in days) to resolution of the acute gout attack
Time frame: 1-28 Days
Pain Day 28
Patient rated pain on a Likert pain score of 0-10
Time frame: Pateints are assessed at five time intervals over 28 days: days 1, 3-4, 10-15, 20-25, and 28; Day 28 reported
Physician Global Assessment of Gout Activity at Day 28
Physician rated gout activity is measured on a Likert scale 0-10.
Time frame: Pateints are assessed at five time intervals over 28 days: days 1, 3-4, 10-15, 20-25, and 28; Day 28 reported
Serum Uric Acid Level
Blood test (serum) for uric acid level
Time frame: day 28
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.